Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis

Myasthenia gravis (MG) is a rare debilitating autoimmune neuromuscular disorder. Many studies have focused on the mechanism and treatment strategies of MG. However, the exact pathogenesis of MG and effective treatment strategies remain unclear. Recent studies have indicated that microRNAs (miRNAs or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Med
Main Authors: Cao, Yuze, Lu, Xiaoyan, Wang, Jianjian, Zhang, Huixue, Liu, Zhaojun, Xu, Si, Wang, Tianfeng, Ning, Shangwei, Xiao, Bo, Wang, Lihua
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5358695/
https://ncbi.nlm.nih.gov/pubmed/28075449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2017.2853
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados